Blue Light Mitigation & Retinal Health — References

Navigation

• Parent Topic: Blue Light Mitigation & Retinal Health
• Reference Hub: 04 - Longevity & Environment References MOC

---

Primary Literature Dossier

1. Shinhmar et al. (2020) & (2021) — Weeklong Improved Colour Contrast Sensitivity After a Single 3-Minute Morning 670 nm Exposure in Aging Humans

• Citation: Shinhmar H, Grewal M, Sivaprasad S, Hogg C, Chong V, Neveu M, Jeffery G. Optically Improved Mitochondrial Function Redeems Aged Human Visual Decline. The Journals of Gerontology: Series A. 2020 Aug 16;75(9):e49-e52. (Followed by Shinhmar H, Hogg C, Neveu M, Jeffery G. Weeklong improved colour contrasts sensitivity after single 670 nm exposures associated with enhanced mitochondrial function. Scientific Reports. 2021 Nov 24;11(1):22872.)
• Identifiers: PMID: 32596723 (PubMed · Europe PMC) (10.1093/gerona/glaa155 (DOI · SciDB)) & PMID: 34819566 (PubMed · Europe PMC) (10.1038/s41598-021-02311-1 (DOI · SciDB))
• Study Design & Sample Size: Prospective human visual psychophysics trials ($n=24$ in 2020 study; $n=20$ in 2021 circadian-timing study, ages 28–72 years; 3-minute exposure to $670\text{ nm}$ LED at $8{\text{ mW/cm}}^2$ in the morning [$08:00\text{–}09:00\text{ AM}$] vs. afternoon [$12:00\text{–}13:00\text{ PM}$]).
• Key Quantitative Outcomes:
  • A single 3-minute morning exposure to $670\text{ nm}$ light improved tritan (blue-yellow, S-cone) color contrast thresholds by an average of 17% across the cohort ($p=0.0003$) and $>20\%$ in older adults (ages 38–70), with the improvement persisting for up to 7 days. Protan (red-green, L/M-cone) thresholds also improved by ~12% ($p=0.0006$) and rod scotopic sensitivity improved in older subjects.
  • Afternoon exposures ($12:00\text{–}13:00\text{ PM}$) produced 0% improvement ($p>0.05$), demonstrating strict circadian gating of photoreceptor mitochondrial responsiveness.

2. AREDS2 Research Group / Chew et al. (2013 & 2022) — Lutein and Zeaxanthin for Age-Related Macular Degeneration

• Citation: Age-Related Eye Disease Study 2 (AREDS2) Research Group; Chew EY, Clemons TE, SanGiovanni JP, Danis RP, Ferris FL 3rd, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013 May 15;309(19):2005-2015. (10-year follow-up: JAMA Ophthalmology 2022; PMID 35653117 (PubMed)).
• Identifiers: PMID: 23644932 (PubMed · Europe PMC) | DOI: 10.1001/jama.2013.4997 (DOI · SciDB · Scholar)
• Study Design & Sample Size: Multicenter, randomized, double-blind, placebo-controlled Phase 3 clinical trial across 82 clinical sites ($n=4,203$ participants aged 50–85 years followed for 5 years, with 10-year extension; $10\text{ mg/day}$ Lutein + $2\text{ mg/day}$ Zeaxanthin).
• Key Quantitative Outcomes:
  • Direct head-to-head comparison showed Lutein + Zeaxanthin reduced progression to advanced AMD by 18% ($\text{HR }0.82,p=0.02$) and neovascular AMD by 22% ($\text{HR }0.78,p=0.01$) compared to beta-carotene, and by 26% ($\text{HR }0.74,p=0.01$) in participants in the lowest quintile of dietary lutein/zeaxanthin intake.
  • 10-year follow-up confirmed sustained long-term retinal neuroprotection without the 2-fold lung cancer risk observed with beta-carotene.

3. Stringham et al. (2017) — Macular Carotenoid Supplementation Improves Visual Performance, Sleep Quality, and Digital Eye Strain in High Screen Time Users

• Citation: Stringham JM, Stringham NT, O’Brien KJ. Macular Carotenoid Supplementation Improves Visual Performance, Sleep Quality, and Adverse Physical Symptoms in Those with High Screen Time Exposure. Foods. 2017 Jun 29;6(7):47.
• Identifiers: PMID: 28672854 (PubMed · Europe PMC) | DOI: 10.3390/foods6070047 (DOI · SciDB · Scholar)
• Study Design & Sample Size: Randomized, double-blind, placebo-controlled 6-month clinical trial ($n=48$ healthy young adults with $\ge 6\text{ hours/day}$ digital screen exposure; $24\text{ mg/day}$ macular carotenoids [Lutein + Zeaxanthin + Meso-Zeaxanthin] vs. placebo).
• Key Quantitative Outcomes:
  • Macular Pigment Optical Density (MPOD) increased significantly from $0.40$ to $0.53$ optical density units ($+32.5\%$, $p<0.001$).
  • Contrast sensitivity ($p<0.001$), photostress recovery time ($-5.1\text{ seconds}$, $p<0.001$), and disability glare thresholds improved significantly, while headache frequency ($-35\%$), eye strain ($-30\%$), eye fatigue ($-29\%$), and Pittsburgh Sleep Quality Index (PSQI) scores improved significantly vs. placebo ($p<0.01$).

4. Marie et al. (2018) — Precise Action Spectrum of Blue Light-Induced Retinal Pigment Epithelium Phototoxicity (415–455 nm)

• Citation: Marie M, Bigot K, Angebault C, Barrau C, Gondouin P, Pagan D, Fouquet S, Villette T, Sahel JA, Lenaers G, Picaud S, Arnault E. Light action spectrum on oxidative stress and mitochondrial damage in A2E-loaded retinal pigment epithelium cells. Cell Death & Disease. 2018 Feb 23;9(3):287.
• Identifiers: PMID: 29476095 (PubMed · Europe PMC) | DOI: 10.1038/s41419-018-0331-5 (DOI · SciDB · Scholar)
• Study Design & Sample Size: High-resolution ($10\text{ nm}$ bandwidth step) photobiological action spectrum study across $390\text{–}520\text{ nm}$ and $630\text{ nm}$ in primary porcine and human $\text{A2E}$-loaded RPE cells at physiological retinal irradiances.
• Key Quantitative Outcomes:
  • Identified the exact phototoxic spectral window between $415\text{ nm}$ and $455\text{ nm}$ (peak toxicity at $430\text{–}440\text{ nm}$), which triggered a 3-fold surge in superoxide/hydrogen peroxide, perinuclear mitochondrial clustering, loss of mitochondrial respiratory spare capacity, and RPE caspase-3 apoptosis—whereas wavelengths $\ge 470\text{ nm}$ ($480\text{ nm}$ circadian cyan) caused minimal RPE oxidative damage.